402 related articles for article (PubMed ID: 27174201)
1. Generation and characterization of integration-free induced pluripotent stem cells from patients with autoimmune disease.
Son MY; Lee MO; Jeon H; Seol B; Kim JH; Chang JS; Cho YS
Exp Mol Med; 2016 May; 48(5):e232. PubMed ID: 27174201
[TBL] [Abstract][Full Text] [Related]
2. Generation of human iPSCs from cells of fibroblastic and epithelial origin by means of the oriP/EBNA-1 episomal reprogramming system.
Drozd AM; Walczak MP; Piaskowski S; Stoczynska-Fidelus E; Rieske P; Grzela DP
Stem Cell Res Ther; 2015 Jun; 6(1):122. PubMed ID: 26088261
[TBL] [Abstract][Full Text] [Related]
3. Generation of Footprint-Free Induced Pluripotent Stem Cells from Human Fibroblasts Using Episomal Plasmid Vectors.
Ovchinnikov DA; Sun J; Wolvetang EJ
Methods Mol Biol; 2015; 1330():37-45. PubMed ID: 26621587
[TBL] [Abstract][Full Text] [Related]
4. Induction of pluripotency in long-term cryopreserved human neonatal fibroblasts in feeder-free condition.
Csobonyeiova M; Krajciova L; Nicodemou A; Polak S; Danisovic L
Cell Tissue Bank; 2017 Mar; 18(1):45-52. PubMed ID: 27873029
[TBL] [Abstract][Full Text] [Related]
5. Reprogramming Methods Do Not Affect Gene Expression Profile of Human Induced Pluripotent Stem Cells.
Trevisan M; Desole G; Costanzi G; Lavezzo E; Palù G; Barzon L
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28117672
[TBL] [Abstract][Full Text] [Related]
6. Transgene-Free Disease-Specific iPSC Generation from Fibroblasts and Peripheral Blood Mononuclear Cells.
Fidan K; Ebrahimi A; Çağlayan ÖH; Özçimen B; Önder TT
Methods Mol Biol; 2016; 1353():215-31. PubMed ID: 26126451
[TBL] [Abstract][Full Text] [Related]
7. Practical Integration-Free Episomal Methods for Generating Human Induced Pluripotent Stem Cells.
Kime C; Rand TA; Ivey KN; Srivastava D; Yamanaka S; Tomoda K
Curr Protoc Hum Genet; 2015 Oct; 87():21.2.1-21.2.21. PubMed ID: 26439714
[TBL] [Abstract][Full Text] [Related]
8. Derivation, Expansion, and Motor Neuron Differentiation of Human-Induced Pluripotent Stem Cells with Non-Integrating Episomal Vectors and a Defined Xenogeneic-free Culture System.
Hu W; He Y; Xiong Y; Lu H; Chen H; Hou L; Qiu Z; Fang Y; Zhang S
Mol Neurobiol; 2016 Apr; 53(3):1589-1600. PubMed ID: 25663198
[TBL] [Abstract][Full Text] [Related]
9. Tumor-Free Transplantation of Patient-Derived Induced Pluripotent Stem Cell Progeny for Customized Islet Regeneration.
El Khatib MM; Ohmine S; Jacobus EJ; Tonne JM; Morsy SG; Holditch SJ; Schreiber CA; Uetsuka K; Fusaki N; Wigle DA; Terzic A; Kudva YC; Ikeda Y
Stem Cells Transl Med; 2016 May; 5(5):694-702. PubMed ID: 26987352
[TBL] [Abstract][Full Text] [Related]
10. Purification of functional reprogramming factors in mammalian cell using FLAG -Tag.
Han MJ; Kim HR; O'Reilly C; Kim CH
Biochem Biophys Res Commun; 2017 Oct; 492(2):154-160. PubMed ID: 28802578
[TBL] [Abstract][Full Text] [Related]
11. Integration-free reprogramming of human somatic cells to induced pluripotent stem cells (iPSCs) without viral vectors, recombinant DNA, and genetic modification.
Heng BC; Fussenegger M
Methods Mol Biol; 2014; 1151():75-94. PubMed ID: 24838880
[TBL] [Abstract][Full Text] [Related]
12. Cell type of origin influences iPSC generation and differentiation to cells of the hematoendothelial lineage.
Phetfong J; Supokawej A; Wattanapanitch M; Kheolamai P; U-Pratya Y; Issaragrisil S
Cell Tissue Res; 2016 Jul; 365(1):101-12. PubMed ID: 26893154
[TBL] [Abstract][Full Text] [Related]
13. Reprogramming of human fibroblasts to induced pluripotent stem cells under xeno-free conditions.
Rodríguez-Pizà I; Richaud-Patin Y; Vassena R; González F; Barrero MJ; Veiga A; Raya A; Izpisúa Belmonte JC
Stem Cells; 2010 Jan; 28(1):36-44. PubMed ID: 19890879
[TBL] [Abstract][Full Text] [Related]
14. Integrated analysis of hematopoietic differentiation outcomes and molecular characterization reveals unbiased differentiation capacity and minor transcriptional memory in HPC/HSC-iPSCs.
Gao S; Hou X; Jiang Y; Xu Z; Cai T; Chen J; Chang G
Stem Cell Res Ther; 2017 Jan; 8(1):13. PubMed ID: 28114969
[TBL] [Abstract][Full Text] [Related]
15. Generation of Induced Pluripotent Stem Cells (iPSCs) from Adult Canine Fibroblasts.
Koh S; Piedrahita JA
Methods Mol Biol; 2015; 1330():69-78. PubMed ID: 26621590
[TBL] [Abstract][Full Text] [Related]
16. Parallel assessment of globin lentiviral transfer in induced pluripotent stem cells and adult hematopoietic stem cells derived from the same transplanted β-thalassemia patient.
Tubsuwan A; Abed S; Deichmann A; Kardel MD; Bartholomä C; Cheung A; Negre O; Kadri Z; Fucharoen S; von Kalle C; Payen E; Chrétien S; Schmidt M; Eaves CJ; Leboulch P; Maouche-Chrétien L
Stem Cells; 2013 Sep; 31(9):1785-94. PubMed ID: 23712774
[TBL] [Abstract][Full Text] [Related]
17. Differentiation of primordial germ cells from induced pluripotent stem cells of primary ovarian insufficiency.
Leng L; Tan Y; Gong F; Hu L; Ouyang Q; Zhao Y; Lu G; Lin G
Hum Reprod; 2015 Mar; 30(3):737-48. PubMed ID: 25586786
[TBL] [Abstract][Full Text] [Related]
18. Differentiation of RPE cells from integration-free iPS cells and their cell biological characterization.
Hazim RA; Karumbayaram S; Jiang M; Dimashkie A; Lopes VS; Li D; Burgess BL; Vijayaraj P; Alva-Ornelas JA; Zack JA; Kohn DB; Gomperts BN; Pyle AD; Lowry WE; Williams DS
Stem Cell Res Ther; 2017 Oct; 8(1):217. PubMed ID: 28969679
[TBL] [Abstract][Full Text] [Related]
19. Efficient hematopoietic redifferentiation of induced pluripotent stem cells derived from primitive murine bone marrow cells.
Pfaff N; Lachmann N; Kohlscheen S; Sgodda M; Araúzo-Bravo MJ; Greber B; Kues W; Glage S; Baum C; Niemann H; Schambach A; Cantz T; Moritz T
Stem Cells Dev; 2012 Mar; 21(5):689-701. PubMed ID: 21732815
[TBL] [Abstract][Full Text] [Related]
20. Human Gingival Integration-Free iPSCs; a Source for MSC-Like Cells.
Umezaki Y; Hashimoto Y; Nishishita N; Kawamata S; Baba S
Int J Mol Sci; 2015 Jun; 16(6):13633-48. PubMed ID: 26084043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
